- 01

Eli Lilly and Company
LLYNew YorkÉtats-Unis
$1.1 Billions
+10.0% 1W·+56.6% 1Y
- 02

Johnson & Johnson (J&J)
JNJNew YorkÉtats-Unis
$616 Milliards
+4.3% 1W·+32.3% 1Y
- 03

AbbVie Inc.
ABBVNew YorkÉtats-Unis
$504 Milliards
+5.4% 1W·+24.3% 1Y
- 04

F. Hoffmann-La Roche AG
ROGSIX SuisseSuisse
$372 Milliards
-6.6% 1W·— 1Y
- 05

Merck & Co., Inc.
MRKNew YorkÉtats-Unis
$360 Milliards
+4.5% 1W·+72.1% 1Y
- 06

Novartis AG
NOVNSIX SuisseSuisse
$286 Milliards
+3.3% 1W·+14.6% 1Y
- 07

AstraZeneca PLC
AZNNew YorkRoyaume-Uni
$257 Milliards
— 1W·-3.2% 1Y
- 08

Pfizer Inc.
PFENew YorkÉtats-Unis
$169 Milliards
+4.6% 1W·— 1Y
- 09

Sanofi S.A.
SNYNew YorkFrance
$97.3 Milliards
+2.1% 1W·-19.8% 1Y
- 10

Jiangsu Hengrui Pharmaceuticals
600276ShanghaiChine
$46.4 Milliards
+4.2% 1W·-23.6% 1Y
- 11

Shanhe Pharmacaps
300452ShenzhenChine
$443 Millions
-4.4% 1W·— 1Y
- 12

Tasly Pharmaceutical Group Co., Ltd.
600535ShanghaiChine
—
— 1W·— 1Y
Affichage de 1–12 sur 12
